P Jitprasertwong1, N Charadram2, S Kumphune3, S Pongcharoen4,5, S Sirisinha6. 1. Department of Preventive Dentistry, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand. 2. Department of Restorative Dentistry, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand. 3. Faculty of Allied Health Science, Biomedical Research Unit in Cardiovascular Sciences, Naresuan University, Phitsanulok, Thailand. 4. Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand. 5. Centre of Excellence in Medical Biotechnology (CEMB), Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand. 6. Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Abstract
BACKGROUND AND OBJECTIVE: Female sex hormones are elevated and are potential host response modifiers during pregnancy. Modulation of immune responses by estrogen and progesterone may be responsible for periodontal inflammation. Therefore, we aimed to investigate the role of β-estradiol and progesterone in human monocyte immune responses, at cellular and molecular levels, to identify their role as a possible immunological link between pregnancy and periodontal disease. MATERIAL AND METHODS: Primary human monocytes were purified from human peripheral blood mononuclear cells by adherent method. Expression of Toll-like receptor (TLR) 2, 4 and CD14 was analyzed by flow cytometry. TLR2, TLR4, cyclooxygenase-2 (COX2), nuclear factor-kappa B (NF-κB) and NF-κB inhibitor-alpha mRNA expressions were measured using real-time reverse transcriptase-polymerase chain reaction and prostaglandin E2 secretion was assayed by enzyme-linked immunosorbent assay. NF-κB expression was also examined by immunofluorescence. Western blotting was performed to determine the activation of mitogen-activated protein kinase pathway. RESULTS: We report herein that both β-estradiol and progesterone significantly reduced TLR2 expression at both protein and mRNA levels but had less of an effect on TLR4 expression in primary human monocytes. We also found that the hormones decreased monocyte cell surface protein expression of CD14. Significantly, β-estradiol and progesterone dose-dependently downregulated monocyte expression of COX2 mRNA. Pretreatment monocytes with β-estradiol or progesterone reduced effects of Porphyromonas gingivalis lipopolysaccharide (LPS) on COX2 mRNA expression and decreased prostaglandin E2 secretion by the monocytes. Furthermore, we demonstrated that both β-estradiol and progesterone inhibited P. gingivalis LPS-induced NF-κB signaling pathway through the upregulation of NF-κB inhibitor-alpha expression. However, neither β-estradiol nor progesterone altered the phosphorylation of the p38, the extracellular signal-regulated kinase 1/2 and the c-Jun N-terminal activated kinase in P. gingivalis LPS-stimulated monocytes. Thus, the inhibitory effects of these hormones on the response of human monocytes to P. gingivalis LPS appear to be independent on mitogen-activated protein kinase signaling pathway. CONCLUSION: The results of the present study suggest that β-estradiol and progesterone could influence the immune response of human monocytes to periodontal pathogens and this process may have a role in the clinical manifestations of periodontal disease associated with pregnancy.
BACKGROUND AND OBJECTIVE: Female sex hormones are elevated and are potential host response modifiers during pregnancy. Modulation of immune responses by estrogen and progesterone may be responsible for periodontal inflammation. Therefore, we aimed to investigate the role of β-estradiol and progesterone in human monocyte immune responses, at cellular and molecular levels, to identify their role as a possible immunological link between pregnancy and periodontal disease. MATERIAL AND METHODS: Primary human monocytes were purified from human peripheral blood mononuclear cells by adherent method. Expression of Toll-like receptor (TLR) 2, 4 and CD14 was analyzed by flow cytometry. TLR2, TLR4, cyclooxygenase-2 (COX2), nuclear factor-kappa B (NF-κB) and NF-κB inhibitor-alpha mRNA expressions were measured using real-time reverse transcriptase-polymerase chain reaction and prostaglandin E2 secretion was assayed by enzyme-linked immunosorbent assay. NF-κB expression was also examined by immunofluorescence. Western blotting was performed to determine the activation of mitogen-activated protein kinase pathway. RESULTS: We report herein that both β-estradiol and progesterone significantly reduced TLR2 expression at both protein and mRNA levels but had less of an effect on TLR4 expression in primary human monocytes. We also found that the hormones decreased monocyte cell surface protein expression of CD14. Significantly, β-estradiol and progesterone dose-dependently downregulated monocyte expression of COX2 mRNA. Pretreatment monocytes with β-estradiol or progesterone reduced effects of Porphyromonas gingivalislipopolysaccharide (LPS) on COX2 mRNA expression and decreased prostaglandin E2 secretion by the monocytes. Furthermore, we demonstrated that both β-estradiol and progesterone inhibited P. gingivalis LPS-induced NF-κB signaling pathway through the upregulation of NF-κB inhibitor-alpha expression. However, neither β-estradiol nor progesterone altered the phosphorylation of the p38, the extracellular signal-regulated kinase 1/2 and the c-Jun N-terminal activated kinase in P. gingivalis LPS-stimulated monocytes. Thus, the inhibitory effects of these hormones on the response of human monocytes to P. gingivalis LPS appear to be independent on mitogen-activated protein kinase signaling pathway. CONCLUSION: The results of the present study suggest that β-estradiol and progesterone could influence the immune response of human monocytes to periodontal pathogens and this process may have a role in the clinical manifestations of periodontal disease associated with pregnancy.
Authors: Sean E DeWolf; Alana A Shigeoka; Andrew Scheinok; Sashi G Kasimsetty; Alexander K Welch; Dianne B McKay Journal: Nephron Date: 2017-06-15 Impact factor: 2.847
Authors: Zeni Wu; Doratha A Byrd; Yunhu Wan; Daniel Ansong; Joe-Nat Clegg-Lamptey; Beatrice Wiafe-Addai; Lawrence Edusei; Ernest Adjei; Nicholas Titiloye; Florence Dedey; Francis Aitpillah; Joseph Oppong; Verna Vanderpuye; Ernest Osei-Bonsu; Casey L Dagnall; Kristine Jones; Amy Hutchinson; Belynda D Hicks; Thomas U Ahearn; Jianxin Shi; Rob Knight; Richard Biritwum; Joel Yarney; Seth Wiafe; Baffour Awuah; Kofi Nyarko; Jonine D Figueroa; Rashmi Sinha; Montserrat Garcia-Closas; Louise A Brinton; Emily Vogtmann Journal: Int J Cancer Date: 2022-06-30 Impact factor: 7.316
Authors: Emily A Voigt; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Krista M Goergen; Daniel J Schaid; Gregory A Poland Journal: Front Immunol Date: 2019-02-27 Impact factor: 8.786
Authors: María Isabel Mendoza-Cabrera; Rosa-Elena Navarro-Hernández; Anne Santerre; Pablo Cesar Ortiz-Lazareno; Ana Laura Pereira-Suárez; Ciro Estrada-Chávez Journal: Innate Immun Date: 2019-07-31 Impact factor: 2.680
Authors: M Ángeles Martínez-García; Miriam Ojeda-Ojeda; Eulalia Rodríguez-Martín; María Insenser; Samuel Moncayo; Francisco Álvarez-Blasco; Manuel Luque-Ramírez; Héctor F Escobar-Morreale Journal: Biomolecules Date: 2020-01-09
Authors: Clarissa Leal Silva E Souza; Camila Dutra Barbosa; Hanna I L N Coelho; Manoel N Santos Júnior; Elaine Novaes Barbosa; Éllunny Chaves Queiroz; Mauro Fernandes Teles; Déborah Cruz Dos Santos; Rafaela Souza Bittencourt; Telma de Jesus Soares; Márcio Vasconcelos Oliveira; Jorge Timenetsky; Guilherme Barreto Campos; Lucas Miranda Marques Journal: Front Cell Infect Microbiol Date: 2021-07-14 Impact factor: 5.293